These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3144168)

  • 21. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
    Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.
    Myerburg RJ; Kessler KM; Cox MM; Huikuri H; Terracall E; Interian A; Fernandez P; Castellanos A
    Circulation; 1989 Dec; 80(6):1571-9. PubMed ID: 2480856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.
    Niazi I; Naccarelli G; Dougherty A; Rinkenberger R; Tchou P; Akhtar M
    J Am Coll Cardiol; 1989 Mar; 13(4):904-10. PubMed ID: 2494243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway.
    Kunze KP; Kuck KH; Schlüter M; Kuch B; Bleifeld W
    Am J Cardiol; 1984 Aug; 54(3):323-9. PubMed ID: 6431796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of encainide and flecainide on chronic ectopic atrial tachycardia.
    Kunze KP; Kuck KH; Schlüter M; Bleifeld W
    J Am Coll Cardiol; 1986 May; 7(5):1121-6. PubMed ID: 3082957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of oral propafenone in the treatment of arrhythmias in infants and children (European retrospective multicenter study). Working Group on Pediatric Arrhythmias and Electrophysiology of the Association of European Pediatric Cardiologists.
    Janousek J; Paul T
    Am J Cardiol; 1998 May; 81(9):1121-4. PubMed ID: 9605053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia.
    Naccarelli GV; Jackman WM; Akhtar M; Rinkenberger RL; Friday KJ; Dougherty AH; Tchou P; Yeung-Lai-Wah JA
    Am J Cardiol; 1988 Dec; 62(19):31L-36L. PubMed ID: 3144165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety considerations and dosing guidelines for encainide in supraventricular arrhythmias.
    Soyka LF
    Am J Cardiol; 1988 Dec; 62(19):63L-68L. PubMed ID: 3144170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supraventricular tachycardia in children.
    Van der Merwe DM; Van der Merwe PL
    Cardiovasc J S Afr; 2004; 15(2):64-9. PubMed ID: 15148540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Encainide versus flecainide in the treatment of chronic resistant paroxysmal atrial tachyarrhythmias.
    Coumel P
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():579-84. PubMed ID: 2125836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supraventricular tachycardia in infants, children and adolescents: diagnosis, and pharmacological and interventional therapy.
    Paul T; Bertram H; Bökenkamp R; Hausdorf G
    Paediatr Drugs; 2000; 2(3):171-81. PubMed ID: 10937468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias.
    Pritchett EL; Wilkinson WE
    Am J Cardiol; 1991 May; 67(11):976-80. PubMed ID: 1902055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
    Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interactions of quinidine and propranolol with mexiletine, encainide, flecainide and tocainide].
    Halawa B
    Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):222-4. PubMed ID: 2120685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A symposium: The use of encainide in supraventricular tachycardias. June 3 and 4, 1988, Bermuda. Proceedings.
    Am J Cardiol; 1988 Dec; 62(19):1L-84L. PubMed ID: 3144162
    [No Abstract]   [Full Text] [Related]  

  • 37. Inefficacy and proarrhythmic effects of flecainide and encainide for sustained ventricular tachycardia and ventricular fibrillation.
    Herre JM; Titus C; Oeff M; Eldar M; Franz MR; Griffin JC; Scheinman MM
    Ann Intern Med; 1990 Nov; 113(9):671-6. PubMed ID: 2121082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term efficacy of atenolol for atrioventricular reciprocating tachycardia in children less than 5 years old.
    Ko JK; Ban JE; Kim YH; Park IS
    Pediatr Cardiol; 2004; 25(2):97-101. PubMed ID: 14648002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.